Results for this period
Interim period (second quarter)1 September 2025–28 February 2026Non-consolidated (standalone)Japanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Growing health awareness and expansion of the recovery-wear market, the launch of 45 fall/winter products, expanded brand recognition, and expanded sales channels.
Not applicable.
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Non-consolidated (standalone) |
| Period Covered | 1 September 2025–28 February 2026 |
| Net Sales | ¥16,471 million |
| Operating profit | ¥2,189 million |
| Ordinary income | ¥2,186 million |
| Profit attributable to owners of the parent | ¥1,531 million |
| Net income per share | ¥203.02 |
| Equity ratio | End of the current fiscal period 55.8 / End of previous period 61.7 |
| Total assets | ¥10,099 million |
| Net assets | ¥5,634 million |
| Cash flows from operating activities | ¥-587,740 thousand |
| Cash flows from investing activities | ¥-608,212 thousand |
| Cash flows from financing activities | ¥-674,720 thousand |
| Cash and cash equivalents at end of period | ¥2,458,533 thousand |
| Full-year earnings forecast | Net Sales ¥33,081 million / Operating profit ¥3,804 million / Ordinary income ¥3,791 million / Net income ¥2,551 million / Net income per share ¥333.20 |
| Revision to Earnings Forecast | Net Sales Not disclosed → ¥33,081 million / Operating profit Not disclosed → ¥3,804 million / Ordinary income Not disclosed → ¥3,791 million / Net income Not disclosed → ¥2,551 million |
| Annual Dividend Forecast | ¥0 → ¥0（0.0%） |
| Depreciation and amortization | ¥127,990 thousand |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Material subsequent events | At a meeting of the Board of Directors held on 14 April 2026, the company resolved to conduct a stock split and amend its Articles of Incorporation. With 30 June 2026 as the record date, each common share will be split into 3 shares, effective 1 July 2026. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Available (participants not specified) |
| Issued Shares at Period-End | 7,656,441 Shares |
| Treasury Shares at Period-End | 150,000 Shares |
| Factors Behind Changes in Business Performance | Growing health awareness and expansion of the recovery-wear market, the launch of 45 fall/winter products, expanded brand recognition, and expanded sales channels. |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Against a backdrop of growing health awareness and an expanding recovery-wear market, the company launched 45 fall/winter products. It also worked to expand brand recognition through collaboration with Samurai Japan and a collaboration with HERALBONY, and to expand its sales channels, including by opening a permanent store at Isetan Shinjuku.